ingenol mebutate
Selected indexed studies
- Ingenol Mebutate. (, 2006) [PMID:33355739]
- Ingenol Mebutate: Expanded Utility. (J Drugs Dermatol, 2020) [PMID:32129959]
- Ingenol Mebutate and the Treatment of Actinic Keratosis. (J Drugs Dermatol, 2021) [PMID:33400406]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Ingenol Mebutate. (2006) pubmed
- Ingenol Mebutate: Expanded Utility. (2020) pubmed
- Ingenol Mebutate and the Treatment of Actinic Keratosis. (2021) pubmed
- Ingenol mebutate in cancer therapy: mechanisms, clinical applications and future directions. (2025) pubmed
- Ingenol mebutate gel 0.015% and 0.05%: in actinic keratosis. (2012) pubmed
- Topical Ingenol Mebutate: A New Treatment Modality for Multiple Actinic Keratoses and Field Cancerization. (2017) pubmed
- Ingenol mebutate for mycosis fungoides. (2019) pubmed
- Pharmacokinetic and pharmacodynamic evaluation of ingenol mebutate for the treatment of actinic keratosis. (2018) pubmed
- Ingenol mebutate: a promising treatment for actinic keratoses and nonmelanoma skin cancers. (2013) pubmed
- Cutaneous squamous cell carcinoma: Incidence, risk factors, diagnosis, and staging. (2018) pubmed